Keywords: endos, requested, conduct, additional, morphidex, trial, endo
Endos requested to conduct additional MorphiDex trial
Article | 28 September 2000
Endo Pharmaceuticals has been requested by the US Food and DrugAdministration to conduct an additional clinical trial of the NMDA-enhanced ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
